From @a_nineties
https://x.com/a_nineties/status/1737725327085019389
FINAL STUDY REPORTS FOR C4591001/BNT162-01 ARE AVALABLE
C4591001:
https://mega.nz/folder/LZJ31KqK#m1Z6XM90LFNaoFn4KGkYgA
BNT162-01:
https://mega.nz/folder/SR5nUAKC#LQ8NT55wTjKy0z_4OW4IAg
uploaded on EMA CDP december 19&20. just saw and re-upped, will be reading these files!
0,2% death rate in ONE month post-booster
this is from p-csr-body
https://mega.nz/folder/LZJ31KqK#m1Z6XM9 ... e/KE4UVYYQ also a LOT more deaths in the vaccine arm prior to the booster dose than previously considered
howwwwwww could this be explained? doesn't make any damn sense! they really timed their trial well, because the increasing infection rates would have screwed them to bits. not sure of the difference between the two crossover groups. also why n SO small??
page 132 has an absolutely devsatating KM curve. not a single "severe" covid case in the placebo arm after ~200 days
but look at how the vax arms start taking off, y i k e s !
as we have all seen with our own eyes, the vaccines are ABSOLUTE JUNK. more cases in the vax arm than in placebo! how does that give 37% efficacy?? and 52.9% overall efficacy for boosters LMAO. this is damning data!
page 147. that looks an AWFUL lot like very directly dose-dependent, doesn't it? neat how well double the dose tracks with double the AEs..
page 152 has booster nr.1 + 1month AEs, but bizarrely only one death, compared to the 47 mentioned previously
i really dont understand how they consistently manage to hide deaths in these summary tables
LOL, "likely" "some protection" until big bad omicron came around, which is when we made variant vaxxes! also the substantial increased "nootraliezinnggg" GMTs after booster is when the VE drops from 60% to 55%
so antibodies aren't a correlate of protection?!?! shocking
hehehehe tozinameran and variant vaccines are non-study vaccines
page 181+182. the text only goes til p175, then come tables and figures. perhaps it picks up again later?
page 224. interval is dose 1 to end of surveillance period. this would be much more valuable as a KM curve, but that's why there isn't one supplied, i reckon.
p556 the narratives start. FOUR pages for the LIST of deaths
lots of the deaths were not reported as adverse events due to being outisde of the post-dose surveillance
"we have updated the subject's disposition to six feet under" lol
we're not supposed to say "
turbo cancer", right? i think the correct terminology is "
hyperprogressive". this poor bastard died in 90 days from the first symptom, "abdominal discomfort"